Related Experiment Videos
Plasma beta-thromboglobulin in acute myocardial infarction
Thrombosis Research
|February 1, 1982
Summary
Plasma beta-thromboglobulin levels are significantly elevated in acute myocardial infarction (AMI) patients, particularly those with severe cases. Levels decrease initially then rise again before normalizing, indicating its dynamic role in AMI.
Area of Science:
- Cardiology
- Hematology
Background:
- Acute myocardial infarction (AMI) involves platelet activation and thrombosis.
- Beta-thromboglobulin (beta-TG) is a marker of platelet activation.
Purpose of the Study:
- To investigate serial plasma beta-thromboglobulin (beta-TG) levels in patients with acute myocardial infarction (AMI).
- To correlate beta-TG levels with clinical severity and disease evolution in AMI survivors.
Main Methods:
- Serial plasma beta-thromboglobulin concentrations were measured in 25 patients with AMI.
- Beta-TG levels were compared to clinical severity and followed over time (presentation, day 3, 2 weeks, 4-6 months).
Main Results:
- Elevated beta-TG levels were observed in 18 of 25 AMI patients on presentation (mean 83 ng/ml vs. normal 26 ng/ml, p < 0.001).
- Severely affected patients exhibited the highest initial beta-TG levels (mean 128 ng/ml).
- Beta-TG levels initially decreased by day 3, then increased by week 2, and normalized by 4-6 months post-infarction.
Conclusions:
- Plasma beta-thromboglobulin is a sensitive indicator of platelet activation in acute myocardial infarction.
- The dynamic pattern of beta-TG levels reflects disease severity and evolution in AMI patients.
- Serial beta-TG measurements may offer prognostic value in the management of acute myocardial infarction.